Scarica l'app Stockscreener
15.25
1.94%
0.29
Precedente Chiudi:
$14.96
Aprire:
$15.29
Volume 24 ore:
17,283
Relative Volume:
0.11
Capitalizzazione di mercato:
$32.82M
Reddito:
-
Utile/perdita netta:
$-563.30K
Rapporto P/E:
-76.40
EPS:
-0.1996
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
+19.80%
1M Prestazione:
+86.89%
6M Prestazione:
-12.86%
1 anno Prestazione:
-36.26%
Intervallo 1D:
$14.99
$15.35
Intervallo di 1 settimana:
$12.70
$15.35
Portata 52W:
$6.27
$39.75
Promis Neurosciences Inc Stock (PMN) Company Profile
Nome
Promis Neurosciences Inc
Settore
Industria
Telefono
416-847-6898
Indirizzo
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
15.25 | 32.20M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
Promis Neurosciences (NASDAQ:PMN) Cut to “Strong Sell” at Wall Street Zen - Defense World
SPHERA FUNDS MANAGEMENT LTD. Acquires Additional Shares in ProMIS Neurosciences Inc. - GuruFocus
ProMIS Neurosciences: Phase 1b Alzheimer's trial fully enrolled and financed, with pivotal data expected in 2026 - TradingView
Is ProMIS Neurosciences Inc. (23J0) stock a safe buy pre earningsJobs Report & Weekly Breakout Stock Alerts - mfd.ru
Published on: 2026-02-10 02:21:08 - baoquankhu1.vn
Guggenheim Remains a Buy on ProMIS Neurosciences (PMN) - The Globe and Mail
Insider Stock Purchases: February 06, 2026 - Quiver Quantitative
ProMIS Neurosciences (PMN) Rating Maintained but Price Target Sl - GuruFocus
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Alzheimer’s biotech ProMIS to stream Guggenheim summit fireside chat - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Profit Review: Can ProMIS Neurosciences Inc. continue delivering strong returnsJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Promis Neurosciences (NASDAQ:PMN) Short Interest Down 14.8% in January - Defense World
ProMIS Neurosciences Announces $75 Million PIPE Financing - The Globe and Mail
ProMIS Neurosciences raises $175 million in PIPE financing By Investing.com - Investing.com South Africa
ProMIS Neurosciences Inc. (PMN) stock: surges 34% after $175M PIPE financing deal - parameter.io
ProMIS Neurosciences Secures $175 Mln In Private Financing - Nasdaq
ProMIS Neurosciences Stock Fluctuates Amid Market Developments - timothysykes.com
ProMIS Neurosciences Signs Multiple Material Agreements - TradingView
ProMIS Neurosciences raises $175 million in PIPE financing - Investing.com
ProMIS Neurosciences stock soars after $175 million private placement By Investing.com - Investing.com South Africa
ProMIS Neurosciences Secures $175 Million in PIPE Financing to Extend Cash Runway and Support Alzheimer’s Disease Clinical Study - Quiver Quantitative
ProMIS Neurosciences stock soars after $175 million private placement - Investing.com
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing - The Manila Times
ProMIS lines up up to $175M to extend runway into 2028, fund Alzheimer’s trial - stocktitan.net
RSI Check: What hedge funds are buying Akoya Biosciences IncQuarterly Trade Summary & Free Reliable Trade Execution Plans - baoquankhu1.vn
ProMIS Neurosciences, Inc. announced that it expects to receive $75.464029 million in funding from a group of investors - marketscreener.com
Aug Breakouts: Whats next for ProMIS Neurosciences Inc stockEarnings Beat & Scalable Portfolio Growth Ideas - baoquankhu1.vn
How cyclical is ProMIS Neurosciences Inc.’s revenue streamMarket Activity Recap & Daily Profit Maximizing Trade Tips - bollywoodhelpline.com
Promis Neurosciences (NASDAQ:PMN) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Quarterly Earnings: Is ProMIS Neurosciences Inc benefiting from innovation trends2025 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
Aug Breakouts: Can ProMIS Neurosciences Inc continue delivering strong returnsBond Market & AI Optimized Trade Strategies - baoquankhu1.vn
Bull Run: What are analysts price targets for DMAAMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Gap Down: Can ProMIS Neurosciences Inc continue delivering strong returnsPortfolio Profit Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Bull Bear: Whats ProMIS Neurosciences Incs historical returnTreasury Yields & Short-Term Trading Alerts - baoquankhu1.vn
ProMIS Neurosciences regains Nasdaq compliance - MSN
US Market Wrap: Is FTAIN exposed to political riskJuly 2025 Gainers & Target Return Focused Stock Picks - baoquankhu1.vn
Gains Report: Does ProMIS Neurosciences Inc outperform in volatile marketsQuarterly Trade Review & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
What is the cash position of ProMIS Neurosciences Inc2025 Volatility Report & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Market Moves: Can ProMIS Neurosciences Inc continue delivering strong returnsMarket Growth Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Institution Moves: What is ProMIS Neurosciences Incs P E ratio telling usEarnings Overview Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
US Market Recap: Can ProMIS Neurosciences Inc continue delivering strong returnsJuly 2025 Volume & High Win Rate Trade Tips - baoquankhu1.vn
Why ProMIS Neurosciences Inc. stock appeals to analystsJuly 2025 Action & Weekly Market Pulse Alerts - Улправда
Is ProMIS Neurosciences Inc. (23J0) stock considered safe havenBreathability and Upper Notes & HOKA model picks for your routine - ulpravda.ru
Can ProMIS Neurosciences Inc. stock beat analyst upgradesWeekly Trend Report & Community Consensus Trade Signals - Улправда
How dovish Fed policy supports ProMIS Neurosciences Inc. (23J0) stockPortfolio Return Report & Reliable Intraday Trade Plans - Улправда
Setup Watch: How dovish Fed policy supports ProMIS Neurosciences Inc 23J0 stockJuly 2025 Market Mood & Smart Swing Trading Alerts - moha.gov.vn
ProMIS Neurosciences launch Phase Ia AβO Alzheimer’s trial - MSN
ProMIS Neurosciences to execute 1-for-25 reverse stock split - MSN
Promis Neurosciences Inc Azioni (PMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Promis Neurosciences Inc Azioni (PMN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Milbury Max A. | Principal Accounting Officer |
Oct 03 '25 |
Buy |
0.49 |
30,392 |
14,929 |
45,389 |
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):